Cargando…

Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer

Localised prostate cancer, in particular, intermediate risk disease, has varied survival outcomes that cannot be predicted accurately using current clinical risk factors. External beam radiotherapy (EBRT) is one of the standard curative treatment options for localised disease and its efficacy is rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkins, Anna, Dearnaley, David, Somaiah, Navita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609338/ https://www.ncbi.nlm.nih.gov/pubmed/26504789 http://dx.doi.org/10.1155/2015/238757

Ejemplares similares

Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation
por: Wilkins, Anna, et al.
Publicado: (2023)

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer
por: Wilkins, Anna C., et al.
Publicado: (2018)

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
por: Anbalagan, Selvakumar, et al.
Publicado: (2021)

The role of radiotherapy in localised and locally advanced prostate cancer
por: Bolla, Michel, et al.
Publicado: (2019)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
por: Parker, C C, et al.
Publicado: (2002)

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer
por: Ferreira, M.R., et al.
Publicado: (2019)

Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer
por: Wilkins, Anna, et al.
Publicado: (2018)

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
por: Wilkins, Anna, et al.
Publicado: (2015)

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment
por: Wilkins, Anna, et al.
Publicado: (2018)

Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers
por: Machiels, Melanie, et al.
Publicado: (2023)

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
por: Dearnaley, David, et al.
Publicado: (2019)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

An ionising radiation-induced specific transcriptional signature of inflammation-associated genes in whole blood from radiotherapy patients: a pilot study
por: Cruz-Garcia, Lourdes, et al.
Publicado: (2021)

A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapy
por: Hart, Jordan, et al.
Publicado: (2020)

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer – a phase I study
por: Ganswindt, U, et al.
Publicado: (2006)

Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching
por: Grimwood, Alexander, et al.
Publicado: (2020)

The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients
por: Tsang, Yat Man, et al.
Publicado: (2017)

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer
por: David, Rowan, et al.
Publicado: (2022)

Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue
por: Bründl, Johannes, et al.
Publicado: (2018)

Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study
por: Plym, Anna, et al.
Publicado: (2020)

Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives
por: Kiełb, Paweł, et al.
Publicado: (2023)

The association of mammary serum antigen (MSA) with the histopathological findings in localised breast cancer.
por: Tjandra, J. J., et al.
Publicado: (1988)

Current Trends in the Management of Localised Prostate Cancer
por: Sibley, G. N. A., et al.
Publicado: (1992)

Joint models for dynamic prediction in localised prostate cancer: a literature review
por: Parr, Harry, et al.
Publicado: (2022)

Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology
por: Sobhani, Faranak, et al.
Publicado: (2021)

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
por: Payne, H, et al.
Publicado: (2011)

First Australian experience of treating localised prostate cancer patients with CyberKnife stereotactic radiotherapy: early PSA response, acute toxicity and quality of life
por: Dixit, Ashutosh, et al.
Publicado: (2017)

Pros and Cons of Focal Therapy for Localised Prostate Cancer
por: Mearini, Luigi, et al.
Publicado: (2011)

Patient preferences for treatment modalities for localised prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007)

Complementary structural and functional abnormalities to localise epileptogenic tissue
por: Horsley, Jonathan J., et al.
Publicado: (2023)

Complementary structural and functional abnormalities to localise epileptogenic tissue
por: Horsley, Jonathan J., et al.
Publicado: (2023)

Incidence of genitourinary complications following radiation therapy for localised prostate cancer
por: David, Rowan V., et al.
Publicado: (2022)

The accuracy of Magnetic Resonance – Cone Beam Computed Tomography soft-tissue matching for prostate radiotherapy
por: Wyatt, Jonathan J., et al.
Publicado: (2019)

Acceptability of dietary and physical activity lifestyle modification for men following radiotherapy or radical prostatectomy for localised prostate cancer: a qualitative investigation
por: Hackshaw-McGeagh, Lucy E., et al.
Publicado: (2017)

Differential proteomic alterations between localised and metastatic prostate cancer
por: Taylor, B S, et al.
Publicado: (2006)

Prognostic Value of CD1B in Localised Prostate Cancer
por: Lee, Cheng-Hsueh, et al.
Publicado: (2019)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
por: Mukherjee, Subhabrata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9s8mdgn88m5a9sl6ph7o5ectkc